Current role
Biotechnology · Healthcare
Board Member
2024-06-17–present
Jonathan E. Freeman, Ph.D.
Board Member
Phio Pharmaceuticals Corp. (PHIO)Equibles does not estimate personal net worth.
About Jonathan E. Freeman, Ph.D.
Jonathan E. Freeman, Ph.D. is recorded as Board Member at Phio Pharmaceuticals Corp. (PHIO) since June 17, 2024. Phio Pharmaceuticals Corp. reported in an 8-K filed September 15, 2025 that Jonathan E. Freeman, Ph.D. was appointed Director, effective September 11, 2025. Phio Pharmaceuticals Corp. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Phio Pharmaceuticals Corp. includes Geert Cauwenbergh (CEO), Geert Cauwenbergh, Dr. Med. Sc. (CEO), Gerrit Dispersyn (CEO and Board Member) and 7 others.
“(1) elected each of the six directors to serve until the Company's 2026 Annual Meeting of Stockholders”
Affiliation history
-
Current
2024-06-17–present
Company network
Leadership on record at Phio Pharmaceuticals Corp.
- Geert Cauwenbergh CEO
- Geert Cauwenbergh, Dr. Med. Sc. CEO
- Gerrit Dispersyn CEO, Board Member
- Robert Bitterman CEO
- Robert J. Bitterman CEO, Chairman, Board Member
- Lisa Carson CFO
- Robert M. Infarinato CFO, Chief Accounting Officer
- Curtis A. Lockshin, Ph.D. Board Member
- David H. Deming Board Member
- Patricia A. Bradford Board Member